| 1. |
Tan BY, Acs G, Apple SK, et al. Phyllodes tumours of the breast: a consensus review. Histopathology, 2016, 68(1): 5-21.
|
| 2. |
Okada N, Hasebe T, Iwasaki M, et al. Metaplastic carcinoma of the breast. Human Pathology, 2010, 41(7): 960-970.
|
| 3. |
Langlands F, Cornford E, Rakha E, et al. Imaging overview of metaplastic carcinomas of the breast: a large study of 71 cases. Br J Radiol, 2016, 89(1064): 20140644.
|
| 4. |
Narayan P, Kostrzewa CE, Zhang ZG, et al. Metaplastic carcinoma of the breast: matched cohort analysis of recurrence and survival. Breast Cancer Res Treat, 2023, 199(2): 355-361.
|
| 5. |
Song Y, Liu X, Zhang G, et al. Unique clinicopathological features of metaplastic breast carcinoma compared with invasive ductal carcinoma and poor prognostic indicators. World J Surg Oncol, 2013, 11: 129.
|
| 6. |
Yoon E, Ding Q, Hunt K, et al. High-grade spindle cell lesions of the breast: Key pathologic and clinical updates. Surg Pathol Clin, 2022, 15(1): 77-93.
|
| 7. |
Kumar M, Kumar M, Nigam JS, et al. Metaplastic carcinoma of the breast-case report and review of literature. Int J Surg Open, 2020, 24: 43-46.
|
| 8. |
Magro G, Salvatorelli L, Puzzo L, et al. Practical approach to diagnosis of bland-looking spindle cell lesions of the breast. Pathologica, 2019, 111(4): 344-360.
|
| 9. |
Al-Nafussi A. Spindle cell tumours of the breast: practical approach to diagnosis. Histopathology, 1999, 35(1): 1-13.
|
| 10. |
Boland MR, Nugent T, Nolan J, et al. Fibromatosis of the breast: a 10-year multi-institutional experience and review of the literature. Breast Cancer, 2021, 28(1): 168-174.
|
| 11. |
Na K, Woo HA, Do SI, et al. Combination of GATA3, SOX-10, and PAX8 in a Comprehensive Panel to Diagnose Breast Cancer Metastases. In Vivo, 2022, 36(1): 473-481.
|
| 12. |
Adem C, Reynolds C, Adlakha H, et al. Wide spectrum screening keratin as a marker of metaplastic spindle cell carcinoma of the breast: an immunohistochemical study of 24 patients. Histopathology, 2002, 40(6): 556-562.
|
| 13. |
Bellino R, Arisio R, D’addato F, et al. Metaplastic breast carcinoma: Pathology and clinical outcome. Anticancer Res, 2003, 23(1B): 669-673.
|
| 14. |
McCart Reed AE, Kalaw EM, Lakhani SR. An update on the molecular pathology of metaplastic breast cancer. Breast Cancer (Dove Med Press), 2021, 13: 161-70.
|
| 15. |
Zhou N, Liu CM, Hou HL, et al. Response to apatinib in chemotherapy-failed advanced spindle cell breast carcinoma. Oncotarget, 2016, 7(44): 72373-72379.
|
| 16. |
Vranic S, Stafford P, Palazzo J, et al. Molecular profiling of the metaplastic spindle cell carcinoma of the breast reveals potentially targetable biomarkers. Clin Breast Cancer, 2020, 20(4): 326-331.
|
| 17. |
Varelanunez R, Perezdevargas I, Varelanunez A. Carcinosarcomas of the breast. Rev Clin Esp, 1964, 94: 13-17.
|
| 18. |
Zein DE, Hughes M, Chen XW, et al. Metaplastic carcinoma of the breast is more aggressive than triple-negative breast cancers. Modern Pathology, 2015, 28: 42A-43A.
|
| 19. |
González-Martínez S, Pérez-Mies B, Carretero-Barrio I, et al. Molecular features of metaplastic breast carcinoma: An infrequent subtype of triple negative breast carcinoma. Cancers (Basel), 2020, 12(7): 1832.
|
